Article thumbnail

Efficacy of Combination Use of Beta-Lactamase Inhibitor with Penicillin and Fluoroquinolones for Antibiotic Prophylaxis in Transrectal Prostate Biopsy

By Katsumi Shigemura, Minori Matsumoto, Kazushi Tanaka, Masuo Yamashita, Soichi Arakawa and Masato Fujisawa
Topics: Original Article
Publisher: The Korean Urological Association
OAI identifier: oai:pubmedcentral.nih.gov:3085624
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother
  2. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
  3. Antimicrobial resistance in Escherichia coli strains from urinary tract infections.
  4. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: Are we putting our patients at risk?
  5. Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan.
  6. (2002). Current guideline for hospital infection control in Japan. Nippon Rinsho
  7. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose.
  8. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.
  9. Emergence of extendedspectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? Clin Infect Dis
  10. Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
  11. Extended-spectrum betalactamase-producing organisms.
  12. Guidelines for prevention of perioperative infections in urological field. 1st ed.
  13. Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
  14. Japanese guidelines for prevention of perioperative infections in urological field.
  15. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
  16. Multi-drug resistant E.coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies--three cases including one death.
  17. Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Tazosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor.
  18. Prevalence and risk factors for extended spectrum beta-lactamase-producing uropathogens in patients with urinary tract infection.
  19. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
  20. Risk factors for acute prostatitis after transrectal biopsy of the prostate.
  21. Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy.
  22. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections.
  23. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.